iGlarLixi

insulin glargine + lixisenatide · Sanofi

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for iGlarLixi, covering 2020-11-13 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate Safety and Efficacy of iGlarLixi in Adult Patients With Type 2 Diabetes Mellitus [Phase 4]